TY - JOUR
T1 - REST promotes ETS1-dependent vascular growth in medulloblastoma
AU - Shaik, Shavali
AU - Maegawa, Shinji
AU - Haltom, Amanda R.
AU - Wang, Feng
AU - Xiao, Xue
AU - Dobson, Tara
AU - Sharma, Ajay
AU - Yang, Yanwen
AU - Swaminathan, Jyothishmathi
AU - Kundra, Vikas
AU - Li, Xiao Nan
AU - Schadler, Keri
AU - Harmanci, Arif
AU - Xu, Lin
AU - Gopalakrishnan, Vidya
N1 - Funding Information:
We would like to thank members of the Gopalakrishnan lab and Dr. Eugenie Kleinerman for helpful discussions. This work was supported by grants from the NIH (5R01‐NS‐079715‐01 and 5R03NS077021‐01), the American Cancer Society (RSG‐09‐273‐01‐DDC), the Cancer Prevention Research Institute of Texas (CPRIT‐RP150301), Addi’s Faith Foundation and the Rally Foundation for Childhood Cancers to V.G. RNA‐Seq library preparation and sequencing were conducted by the MD Anderson Cancer Center Science Park Next Generation Sequencing Core, supported by CPRIT Core Facility grant (RP170002).
Publisher Copyright:
© 2021 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
PY - 2021/5
Y1 - 2021/5
N2 - Expression of the RE1-silencing transcription factor (REST), a master regulator of neurogenesis, is elevated in medulloblastoma (MB) tumors. A cell-intrinsic function for REST in MB tumorigenesis is known. However, a role for REST in the regulation of MB tumor microenvironment has not been investigated. Here, we implicate REST in remodeling of the MB vasculature and describe underlying mechanisms. Using RESTTG mice, we demonstrate that elevated REST expression in cerebellar granule cell progenitors, the cells of origin of sonic hedgehog (SHH) MBs, increased vascular growth. This was recapitulated in MB xenograft models and validated by transcriptomic analyses of human MB samples. REST upregulation was associated with enhanced secretion of proangiogenic factors. Surprisingly, a REST-dependent increase in the expression of the proangiogenic transcription factor E26 oncogene homolog 1, and its target gene encoding the vascular endothelial growth factor receptor-1, was observed in MB cells, which coincided with their localization at the tumor vasculature. These observations were confirmed by RNA-Seq and microarray analyses of MB cells and SHH-MB tumors. Thus, our data suggest that REST elevation promotes vascular growth by autocrine and paracrine mechanisms.
AB - Expression of the RE1-silencing transcription factor (REST), a master regulator of neurogenesis, is elevated in medulloblastoma (MB) tumors. A cell-intrinsic function for REST in MB tumorigenesis is known. However, a role for REST in the regulation of MB tumor microenvironment has not been investigated. Here, we implicate REST in remodeling of the MB vasculature and describe underlying mechanisms. Using RESTTG mice, we demonstrate that elevated REST expression in cerebellar granule cell progenitors, the cells of origin of sonic hedgehog (SHH) MBs, increased vascular growth. This was recapitulated in MB xenograft models and validated by transcriptomic analyses of human MB samples. REST upregulation was associated with enhanced secretion of proangiogenic factors. Surprisingly, a REST-dependent increase in the expression of the proangiogenic transcription factor E26 oncogene homolog 1, and its target gene encoding the vascular endothelial growth factor receptor-1, was observed in MB cells, which coincided with their localization at the tumor vasculature. These observations were confirmed by RNA-Seq and microarray analyses of MB cells and SHH-MB tumors. Thus, our data suggest that REST elevation promotes vascular growth by autocrine and paracrine mechanisms.
KW - NRSF
KW - REST
KW - medulloblastoma
KW - tumor microenvironment
KW - vasculature
UR - http://www.scopus.com/inward/record.url?scp=85100580925&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85100580925&partnerID=8YFLogxK
U2 - 10.1002/1878-0261.12903
DO - 10.1002/1878-0261.12903
M3 - Article
C2 - 33469989
AN - SCOPUS:85100580925
SN - 1574-7891
VL - 15
SP - 1486
EP - 1506
JO - Molecular oncology
JF - Molecular oncology
IS - 5
ER -